ARTICLE | Clinical News
AP301 regulatory update
February 15, 2010 8:00 AM UTC
FDA granted Orphan Drug designation to Apeptico's AP301 to prevent ischemia reperfusion injury in the lung during lung transplantation. The human tumor necrosis factor (TNF) alpha-derived peptide als...